KLEIN JOSEPH III sold 47.9% of their position (10.11K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $743.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/5/2026ACC: 0000874015-26-000182
-10.11K
Net shares
Net seller
$743.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10.11K acquired · 20.22K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10.11K
Price / share
$47.11
Trade value
$476.33K
% of position
91.8%
5/1/2026
11.01K→21.13K
Common Stock
Direct
Shares
−8.68K
Price / share
$73.35
Trade value
$636.70K
% of position
41.1%
5/1/2026
21.13K→12.45K
Common Stock
Direct
Shares
−1.43K
Price / share
$74.45
Trade value
$106.53K
% of position
11.5%
5/1/2026
12.45K→11.01K
Total
Net shares
+0.00
Net value
-$266.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +10.11K | $47.11 | $476.33K | 91.8% | 11.01K | 21.13K |
| Common Stock Direct | 5/1/2026 | S · Sale | −8.68K | $73.35 | $636.70K | 41.1% | 21.13K | 12.45K |
| Common Stock Direct | 5/1/2026 | S · Sale | −1.43K | $74.45 | $106.53K | 11.5% | 12.45K | 11.01K |
| Total | +0.00 | -$266.91K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
10.11K shares
Shares
−10.11K
Strike price
47.11
Held after
0.00
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock10.11K shares | 5/1/2026 | M · Option Exercise | −10.11K | 47.11 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned100.00
Total
100.00 indirect100.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100.00 | Indirect |
| Total | 100.00 | 100.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported